Buparlisib
- Generic Name
- Buparlisib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21F3N6O2
- CAS Number
- 944396-07-0
- Unique Ingredient Identifier
- 0ZM2Z182GD
- Background
Buparlisib has been used in trials studying the treatment and basic science of Lymphoma, Metastases, Lung Cancer, Solid Tumors, and Breast Cancer, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath